HCA Healthcare, Inc. HCA
HCA Healthcare, Inc. financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $75.6B | $70.6B | $65.0B | $60.2B | $58.8B | $51.5B | $51.3B | $46.7B | $43.6B | $41.5B |
| Interest expense | $2.2B | $2.1B | $1.9B | $1.7B | $1.6B | $1.6B | $1.8B | $1.8B | $1.7B | $1.7B |
| Income tax | $2.0B | $1.9B | $1.6B | $1.7B | $2.1B | $1.0B | $1.1B | $946.0M | $1.6B | $1.4B |
| Net income | $6.8B | $5.8B | $5.2B | $5.6B | $7.0B | $3.8B | $3.5B | $3.8B | $2.2B | $2.9B |
| EPS (diluted) | $28.33 | $22.00 | $18.97 | $19.15 | $21.16 | $10.93 | $10.07 | $10.66 | $5.95 | $7.30 |
| Operating cash flow | $12.6B | $10.5B | $9.4B | $8.5B | $9.0B | $9.2B | $7.6B | $6.8B | $5.4B | $5.7B |
| Free cash flow | $7.7B | $5.6B | $4.7B | $4.1B | $5.4B | $6.4B | $3.4B | $3.2B | $2.4B | $2.9B |
| Cash & equivalents | $1.0B | $1.9B | $935.0M | $908.0M | $1.5B | $1.8B | $621.0M | $502.0M | $732.0M | $646.0M |
| Inventory | $1.7B | $1.7B | $2.0B | $2.1B | $2.0B | $2.0B | $1.8B | $1.7B | $1.6B | $1.5B |
| Total assets | $60.7B | $59.5B | $56.2B | $52.4B | $50.7B | $47.5B | $45.1B | $39.2B | $36.6B | $33.8B |
| Total liabilities | — | — | — | — | — | — | $45.6B | $42.1B | $41.6B | $39.4B |
| Shareholders' equity | -$6.0B | -$2.5B | -$1.8B | -$2.8B | $1.5B | $2.9B | -$2.8B | -$5.0B | -$6.8B | -$7.3B |
Growth · year-over-year · Revenue CAGR 6.9%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +7.1% | +8.7% | +7.9% | +2.5% | +14.0% | +0.4% | +10.0% | +7.0% | +5.1% | — |
| Net income growth | +17.8% | +9.9% | -7.1% | -18.9% | +85.3% | +7.1% | -7.4% | +70.9% | -23.3% | +35.7% |
| EPS growth | +28.8% | +16.0% | -0.9% | -9.5% | +93.6% | +8.5% | -5.5% | +79.2% | -18.5% | +46.3% |
| Free cash flow growth | +36.4% | +20.3% | +13.6% | -23.3% | -15.9% | +85.7% | +8.0% | +32.2% | -16.7% | +22.6% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.